Tyche Wealth Partners LLC Grows Stock Position in UnitedHealth Group Incorporated $UNH

Tyche Wealth Partners LLC raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 8.3% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,127 shares of the healthcare conglomerate’s stock after purchasing an additional 394 shares during the period. Tyche Wealth Partners LLC’s holdings in UnitedHealth Group were worth $1,599,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in UNH. Brighton Jones LLC lifted its holdings in UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after purchasing an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC increased its stake in shares of UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after acquiring an additional 2,324 shares during the last quarter. Wedge Capital Management L L P NC increased its stake in shares of UnitedHealth Group by 10.8% during the 1st quarter. Wedge Capital Management L L P NC now owns 20,461 shares of the healthcare conglomerate’s stock valued at $10,716,000 after acquiring an additional 1,997 shares during the last quarter. First Citizens Bank & Trust Co. increased its stake in shares of UnitedHealth Group by 5.0% during the 1st quarter. First Citizens Bank & Trust Co. now owns 40,443 shares of the healthcare conglomerate’s stock valued at $21,182,000 after acquiring an additional 1,923 shares during the last quarter. Finally, Wesbanco Bank Inc. increased its stake in shares of UnitedHealth Group by 0.7% during the 1st quarter. Wesbanco Bank Inc. now owns 52,206 shares of the healthcare conglomerate’s stock valued at $27,343,000 after acquiring an additional 338 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on UNH shares. Sanford C. Bernstein upped their price objective on shares of UnitedHealth Group from $337.00 to $379.00 and gave the company an “outperform” rating in a research note on Friday, September 5th. Oppenheimer dropped their target price on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a research report on Wednesday, July 30th. Bank of America increased their target price on shares of UnitedHealth Group from $290.00 to $325.00 and gave the stock a “neutral” rating in a research report on Monday, August 18th. Royal Bank Of Canada dropped their target price on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a research report on Wednesday, July 30th. Finally, Truist Financial increased their target price on shares of UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a research report on Tuesday, September 9th. Sixteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat, UnitedHealth Group has a consensus rating of “Hold” and a consensus target price of $358.95.

UnitedHealth Group Stock Down 0.3%

Shares of NYSE:UNH opened at $358.95 on Tuesday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The company has a 50 day moving average of $309.38 and a two-hundred day moving average of $352.34. The company has a market capitalization of $325.09 billion, a price-to-earnings ratio of 15.55, a price-to-earnings-growth ratio of 2.34 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same period last year, the business earned $6.80 EPS. The firm’s revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.